Catherine Wells, NP
Nurse Practitioner · Jackson, MSNPI 1841365152
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (32.1%), grants and education — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Vantive US Healthcare LLC at 39.0% of the total. 2025 is the largest year on record at $5,836, 2.5 times the $2,359 reported in 2023. Among nurse practitioner clinicians in MS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 35 payments — averaging $244.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vantive US Healthcare LLC$3K
- Travere Therapeutics, Inc.$2K
- AstraZeneca$2K
- Aurinia Pharma U.S., Inc.$125
- Novartis$119
- Baxter Healthcare$111
- plus $71 from 3 others
Across 12 payments — averaging $5540.31 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Fresenius USA Marketing, Inc.$63K
- Fresenius Medical Care Renal Therapies Group, LLC.$3K
What the payments were for
- Grants$2,39028%
- Travel & lodging$2,73832%
- Food & beverage$1,34416%
- Education$2,07024%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vantive US Healthcare LLC | 10 | $3,331 |
| Travere Therapeutics, Inc. | 12 | $2,395 |
| AstraZeneca | 1 | $2,390 |
| Aurinia Pharma U.S., Inc. | 1 | $125 |
| Novartis | 6 | $119 |
| Baxter Healthcare | 2 | $111 |
| Ardelyx, Inc. | 1 | $27 |
| Genentech, Inc. | 1 | $25 |
| Nxstage Medical, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Renal - Acute$3,019
- LUPKYNIS$125
How this compares
$8,543 in reported general payments places this provider in the 95th percentile of 1,090 nurse practitioner providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 28 | $29,471 |
| Sevelamer Carbonate | 26 | $3,026 |
| Nifedipine ErNifedipine | 19 | $979 |
| Calcitriol | 40 | $775 |
| Torsemide | 18 | $431 |
| Allopurinol | 55 | $412 |
| Furosemide | 28 | $311 |
| Losartan Potassium | 30 | $304 |
| Hydralazine Hcl | 14 | $280 |
| Carvedilol | 31 | $167 |
| Spironolactone | 17 | $121 |
| Famotidine | 17 | $107 |
| Amlodipine Besylate | 12 | $48 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga | $2,390 | $29,47128 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,090 nurse practitioner providers in Mississippi.
Other nurse practitioner in Jackson
- Jo Anna WarrenJackson$73K
- Michelle TharpJackson$28K
- Jennifer HollyJackson$16K
- Brandon ChambersJackson$12K
- Ramona BallJackson$9K
- Bonney SimmonsJackson$9K
- Tamecia HerbertJackson$8K
- Amy HeidelbergJackson$7K
- Amy LemlyJackson$6K
- Jennifer PateJackson$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.